Page last updated: 2024-10-31

metyrapone and Focal Neurologic Deficits

metyrapone has been researched along with Focal Neurologic Deficits in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Rinne, UK1
Ott, JE1
Robinson, A1

Reviews

1 review available for metyrapone and Focal Neurologic Deficits

ArticleYear
Cerebral gigantism.
    American journal of diseases of children (1960), 1969, Volume: 117, Issue:3

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Age Determination by Skeleton; Anthropometry; Body Heigh

1969

Other Studies

1 other study available for metyrapone and Focal Neurologic Deficits

ArticleYear
Corticotrophin secretion capacity in multiple sclerosis.
    European neurology, 1968, Volume: 1, Issue:4

    Topics: 17-Hydroxycorticosteroids; 17-Ketosteroids; Acute Disease; Adrenocorticotropic Hormone; Adult; Chron

1968